Swedbank AB Buys 272,913 Shares of Henry Schein, Inc. $HSIC

Swedbank AB lifted its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 30.9% in the 2nd quarter, Holdings Channel reports. The fund owned 1,156,398 shares of the company’s stock after acquiring an additional 272,913 shares during the quarter. Swedbank AB’s holdings in Henry Schein were worth $84,475,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Radnor Capital Management LLC increased its position in shares of Henry Schein by 1.6% during the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after acquiring an additional 180 shares in the last quarter. UMB Bank n.a. increased its position in shares of Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after acquiring an additional 201 shares in the last quarter. HB Wealth Management LLC increased its position in shares of Henry Schein by 1.5% during the first quarter. HB Wealth Management LLC now owns 15,419 shares of the company’s stock worth $1,056,000 after acquiring an additional 226 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Henry Schein by 1.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock worth $1,155,000 after acquiring an additional 229 shares in the last quarter. Finally, Allworth Financial LP increased its position in shares of Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock worth $78,000 after acquiring an additional 232 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

HSIC opened at $68.55 on Friday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.31 billion, a price-to-earnings ratio of 22.11, a PEG ratio of 2.22 and a beta of 0.86. The company’s fifty day moving average price is $68.86 and its two-hundred day moving average price is $69.38.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein’s quarterly revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on HSIC. Baird R W downgraded shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 14th. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Barrington Research cut their target price on shares of Henry Schein from $86.00 to $78.00 and set an “outperform” rating for the company in a research note on Wednesday, August 6th. Finally, Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Sunday, September 7th. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $76.67.

Get Our Latest Stock Report on Henry Schein

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.